Compare Stocks: NUWE, NDRA, MBAI, and NVNO

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MBAI Check-Cap	$6.40 -3.0%	$7.63	$4.80 ▼ $27.44	$9.08M	0.67	28,840 shs	31,407 shs
NDRA ENDRA Life Sciences	$5.62 -2.8%	$5.02	$2.96 ▼ $9.85	$8.68M	-0.05	46,342 shs	5,761 shs
NUWE Nuwellis	$0.77 +0.7%	$1.78	$0.71 ▼ $183.05	$2.80M	0.23	1.62 million shs	137,490 shs
NVNO enVVeno Medical	$10.49 -5.7%	$10.87	$8.67 ▼ $35.70	$7.73M	1.06	19,932 shs	54,139 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MBAI Check-Cap	-3.03%	-1.54%	-23.49%	-34.22%	+639,999,900.00%
NDRA ENDRA Life Sciences	-2.77%	-7.11%	+25.73%	+23.25%	+32.24%
NUWE Nuwellis	+0.74%	-0.88%	-45.11%	-84.54%	-99.46%
NVNO enVVeno Medical	-5.67%	-9.17%	-4.55%	+4.90%	-58.37%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MBAI Check-Cap	$6.40 -3.0%	$7.63	$4.80 ▼ $27.44	$9.08M	0.67	28,840 shs	31,407 shs
NDRA ENDRA Life Sciences	$5.62 -2.8%	$5.02	$2.96 ▼ $9.85	$8.68M	-0.05	46,342 shs	5,761 shs
NUWE Nuwellis	$0.77 +0.7%	$1.78	$0.71 ▼ $183.05	$2.80M	0.23	1.62 million shs	137,490 shs
NVNO enVVeno Medical	$10.49 -5.7%	$10.87	$8.67 ▼ $35.70	$7.73M	1.06	19,932 shs	54,139 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MBAI Check-Cap	-3.03%	-1.54%	-23.49%	-34.22%	+639,999,900.00%
NDRA ENDRA Life Sciences	-2.77%	-7.11%	+25.73%	+23.25%	+32.24%
NUWE Nuwellis	+0.74%	-0.88%	-45.11%	-84.54%	-99.46%
NVNO enVVeno Medical	-5.67%	-9.17%	-4.55%	+4.90%	-58.37%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MBAI Check-Cap	1.00	Sell	N/A	N/A
NDRA ENDRA Life Sciences	2.00	Hold	$25.00	344.84% Upside
NUWE Nuwellis	1.00	Sell	N/A	N/A
NVNO enVVeno Medical	2.33	Hold	N/A	N/A

Current Analyst Ratings Breakdown

Latest NUWE, NDRA, MBAI, and NVNO Analyst Ratings

Date	Company	Brokerage	Action	Rating
9/10/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/13/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/31/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/21/2026	MBAI Check-Cap	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/17/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/7/2026	NVNO enVVeno Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
7/6/2026	NVNO enVVeno Medical	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
6/30/2026	NVNO enVVeno Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
6/24/2026	NUWE Nuwellis	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/15/2026	NVNO enVVeno Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 9/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MBAI Check-Cap	N/A	N/A	$3.86 per share	1.66	$3.30 per share	N/A
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	$1.92 per share	N/A
NUWE Nuwellis	$9.01M	0.31	N/A	N/A	$55.31 per share	0.01
NVNO enVVeno Medical	N/A	N/A	N/A	N/A	$41.38 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MBAI Check-Cap	$4.14M	-$14.07	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NDRA ENDRA Life Sciences	-$7.03M	-$6.38	N/A	N/A	N/A	N/A	-246.34%	-150.81%	11/13/2026 (Estimated)
NUWE Nuwellis	-$17.52M	-$132.59	N/A	N/A	N/A	-123.38%	-623.14%	-147.34%	11/11/2026 (Estimated)
NVNO enVVeno Medical	-$19.47M	-$19.33	N/A	N/A	N/A	N/A	-62.28%	-56.83%	10/30/2026 (Estimated)

Latest NUWE, NDRA, MBAI, and NVNO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2026	Q2 2026	NDRA ENDRA Life Sciences	-$0.84	-$0.63	+$0.21	$0.06	$0.10 million	N/A
8/13/2026	Q2 2026	NUWE Nuwellis	-$23.80	-$26.64	-$2.84	-$26.64	$2.42 million	$1.97 million
7/30/2026	Q2 2026	NVNO enVVeno Medical	-$4.69	-$5.37	-$0.68	-$5.37	$1.00 million	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
MBAI Check-Cap	N/A	N/A	N/A	N/A	N/A
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A
NVNO enVVeno Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MBAI Check-Cap	N/A	0.05	0.05
NDRA ENDRA Life Sciences	N/A	7.10	7.10
NUWE Nuwellis	N/A	1.97	1.54
NVNO enVVeno Medical	N/A	11.70	11.70

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MBAI Check-Cap	1.07%
NDRA ENDRA Life Sciences	1.19%
NUWE Nuwellis	3.13%
NVNO enVVeno Medical	34.71%

Insider Ownership

Company	Insider Ownership
MBAI Check-Cap	0.48%
NDRA ENDRA Life Sciences	10.00%
NUWE Nuwellis	1.60%
NVNO enVVeno Medical	15.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MBAI Check-Cap	80	1.38 million	1.37 million	N/A
NDRA ENDRA Life Sciences	20	1.50 million	1.35 million	Not Optionable
NUWE Nuwellis	70	3.65 million	3.59 million	Not Optionable
NVNO enVVeno Medical	30	690,000	591,000	No Data

NUWE, NDRA, MBAI, and NVNO Headlines

Recent News About These Companies

enVVeno Medical Corporation: enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-Demand

September 11 at 7:16 AM | finanznachrichten.de

enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-Demand

September 11 at 7:00 AM | accessnewswire.comA

enVVeno Medical Participates in the Virtual Investor ‘Why Now’ On-Demand Conference

August 29, 2026 | palmbeachpost.comP

enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference

August 27, 2026 | finance.yahoo.com

enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference

August 27, 2026 | accessnewswire.comA

Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to ...

August 4, 2026 | finance.yahoo.com

Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatments

August 4, 2026 | accessnewswire.comA

enVVeno Medical Corporation: enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement ...

July 31, 2026 | finanznachrichten.de

enVVeno Medical wins FDA IDE for non-surgical transcatheter replacement venous valve

July 31, 2026 | massdevice.com

enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve

July 31, 2026 | accessnewswire.comA

enVVeno Medical Corp.

July 16, 2026 | barrons.com

enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor “What This Means” Segment

July 15, 2026 | oklahoman.comO

enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment

July 15, 2026 | accessnewswire.comA

enVVeno Medical Updates Investors With New Presentation

July 15, 2026 | tipranks.com

enVVeno Medical Corporation: enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial

July 7, 2026 | finanznachrichten.de

enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial

July 7, 2026 | accessnewswire.comA

enVVeno Medical Earnings Estimates, EPS & Revenue | NASDAQ:NVNO

June 25, 2026 | benzinga.com

enVVeno Medical to Present in the Webull Corporate Connect Webinar Series

June 22, 2026 | accessnewswire.comA

enVVeno Medical to Participate in the Virtual Investor Closing Bell Series

June 2, 2026 | accessnewswire.comA

enVVeno Medical Corporation: enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment

May 12, 2026 | finanznachrichten.de

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, NDRA, MBAI, and NVNO Company Descriptions

Check-Cap NASDAQ:MBAI

$6.40 -0.20 (-3.03%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$6.30 -0.10 (-1.48%)

As of 09/11/2026 04:12 PM Eastern

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

ENDRA Life Sciences NASDAQ:NDRA

$5.62 -0.16 (-2.77%)

Closing price 09/11/2026 03:59 PM Eastern

Extended Trading

$5.60 -0.01 (-0.27%)

As of 09/11/2026 07:30 PM Eastern

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Nuwellis NASDAQ:NUWE

$0.77 +0.01 (+0.74%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$0.76 -0.02 (-2.07%)

As of 09/11/2026 07:57 PM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

enVVeno Medical NASDAQ:NVNO

$10.49 -0.63 (-5.67%)

Closing price 09/11/2026 03:56 PM Eastern

Extended Trading

$9.91 -0.58 (-5.54%)

As of 09/11/2026 05:52 PM Eastern

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NUWE, NDRA, MBAI, and NVNO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NUWE, NDRA, MBAI, and NVNO Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NUWE, NDRA, MBAI, and NVNO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, NDRA, MBAI, and NVNO Company Descriptions

Check-Cap NASDAQ:MBAI

ENDRA Life Sciences NASDAQ:NDRA

Nuwellis NASDAQ:NUWE

enVVeno Medical NASDAQ:NVNO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NUWE, NDRA, MBAI, and NVNO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NUWE, NDRA, MBAI, and NVNO Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NUWE, NDRA, MBAI, and NVNO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, NDRA, MBAI, and NVNO Company Descriptions

Check-Cap NASDAQ:MBAI

ENDRA Life Sciences NASDAQ:NDRA

Nuwellis NASDAQ:NUWE

enVVeno Medical NASDAQ:NVNO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools